Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma

• Published in: Frontiers in oncology Vol. 11; p. 654689
• Main Authors: Xu, Xiaofeng, Chen, Diyu, Feng, Xiaode, Hu, Jiating, Ge, Jiangzhen, Yan, Chaobiao, Zhang, Deguo, Ling, Zhenan, Chen, Jianzhong, Wu, Jian
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 31.03.2021
• Subjects: apolipoprotein B; cholangiocarcinoma; immune; methylation; microenvironment; Oncology; microenvironment; immune; apolipoprotein B; cholangiocarcinoma; methylation
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2021.654689

Cholangiocarcinoma (CCA) is a kind of devastating malignancy, which is correlated with the extremely high mortality. Due to the occult pathogenesis of CCA, most patients are diagnosed in the advanced stage. However, the efficacy of chemotherapy and immunotherapy is limited for these patients. The cause for this phenomenon is unclear, the recent researches indicate that it could be related to predisposing genetic factors and tumor microenvironment (TME) changes. The TME is created by the tumor and dominated by tumor-induced interactions. And the tumor prognosis could be influenced by the extent of infiltrating immune cells and stromal cells in TME. The abundance ratio of immune cells for each sample was obtained the CIBERSORT algorithm, and we used ESTIMATE score system to calculate the immune and stromal scores in CCA. The CCA cases in TCGA database were categorized into high and low score groups according to their immune/stromal scores. And then, we identified the differential expressed genes (DEGs) in two groups. Functional enrichment analysis and protein-protein interaction networks were carried out for DEGs. Interestingly, we found out that apolipoprotein B (APOB) is the most down-regulated among these genes. Then we performed the immunohistochemistry staining of APOB in a CCA tumor microarray which contained 100 CCA cases, APOB was down-regulated in CCA samples. Thus, we evaluated the APOB function in the TME of CCA through TIMER. The results demonstrate that the infiltration degree of immune cells in CCA could be influenced by the expression of APOB, and the APOB expression could be mediated by DNA methylation. Our study not only indicates APOB is a potential target for CCA immunotherapy but also provides new ideas for researchers to explore the immunotherapy of various tumors.